Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Operating Expenses: 2020-2023

Historic Operating Expenses for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $33.2 million.

  • Therapeutics' Operating Expenses rose 35.96% to $33.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $127.1 million, marking a year-over-year increase of 45.51%. This contributed to the annual value of $127.1 million for FY2023, which is 45.51% up from last year.
  • Therapeutics' Operating Expenses amounted to $33.2 million in Q4 2023, which was down 2.07% from $33.9 million recorded in Q3 2023.
  • Therapeutics' Operating Expenses' 5-year high stood at $33.9 million during Q3 2023, with a 5-year trough of $13.8 million in Q2 2020.
  • Moreover, its 3-year median value for Operating Expenses was $21.5 million (2022), whereas its average is $24.0 million.
  • Data for Therapeutics' Operating Expenses shows a peak YoY soared of 56.47% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Therapeutics' Operating Expenses stood at $14.4 million in 2020, then soared by 30.60% to $18.8 million in 2021, then skyrocketed by 30.02% to $24.4 million in 2022, then skyrocketed by 35.96% to $33.2 million in 2023.
  • Its Operating Expenses stands at $33.2 million for Q4 2023, versus $33.9 million for Q3 2023 and $28.4 million for Q2 2023.